Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

Key value for chemical safety assessment

Skin sensitisation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

The substance is not considered to have sensitising properties, based on reliable in vivo skin sensitisation studies in guinea pigs with the substance and/or with suitable surrogate substances (read-across): the moderately to very soluble molybdenum substance sodium molybdate, ammonium dimolybdate, molybdenum trioxide and roasted molybdenite concentrate did not show any sensitising effects in reliable guinea pig maximisation studies. The inert substance MoS2 also was not sensitising.

 

To avoid unnecessary (animal) testing, a comprehensive grouping and read-across concept has been developed amongst several molybdenum containing substances. This grouping/category approach is described in detail in a separate report, in accordance with the ECHA's "Read-Across Assessment Framework" (RAAF). This document is attached to section 13 in the technical dosser and to the CSR.

 

The main conclusion is that read-across/grouping of molybdenum substances is justified for systemic effects, including sensitisation, based on the formation of the molybdate ion from all substances in the category, as the driver for any toxicity. The non-molybdenum moieties in the substances, such as iron, ammonium, calcium or sodium do not contribute to toxicity, or at least to a lesser extent than the molybdenum moiety. The substances for which skin sensitisation studies are available are moderately to very soluble and represent worst-case surrogates for less soluble molybdenum substances. For details, see “read-across document” in IUCLID section 13.

 

In conclusion, the registered substance is not considered to have sensitising properties, and no hazard classification is required for sensitisation.

 



Justification for classification or non-classification

The substance is not considered to have sensitising properties, based on reliable in vivo skin sensitisation studies in guinea pigs with the substance and/or with suitable surrogate substances (read-across): the moderately to very soluble molybdenum substance sodium molybdate, ammonium dimolybdate, molybdenum trioxide and roasted molybdenite concentrate did not show any sensitising effects in reliable guinea pig maximisation studies. The inert substance MoS2 also was not sensitising.

 

To avoid unnecessary (animal) testing, a comprehensive grouping and read-across concept has been developed amongst several molybdenum containing substances. This grouping/category approach is described in detail in a separate report, in accordance with the ECHA's "Read-Across Assessment Framework" (RAAF). This document is attached to section 13 in the technical dosser and to the CSR.

 

The main conclusion is that read-across/grouping of molybdenum substances is justified for systemic effects, including sensitisation, based on the formation of the molybdate ion from all substances in the category, as the driver for any toxicity. The non-molybdenum moieties in the substances, such as iron, ammonium, calcium or sodium do not contribute to toxicity, or at least to a lesser extent than the molybdenum moiety. The substances for which skin sensitisation studies are available are moderately to very soluble and represent worst-case surrogates for less soluble molybdenum substances. For details, see “read-across document” in IUCLID section 13.

 

In conclusion, the registered substance is not considered to have sensitising properties, and no hazard classification is required for sensitisation.